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SPENDING MORE TO SPEND LESS: COST AND COST-EFFECTIVENESS OF A DEMAND CREATION 
INTERVENTION TO INCREASE UPTAKE OF VOLUNTARY MEDICAL MALE CIRCUMCISION IN 
TANZANIA: SPENDING MORE TO SPEND LESS 
 
INTRODUCTION 
Male circumcision has been demonstrated to reduce the risk of male acquisition of HIV (1-3). 
Following the WHO and UNAIDS recommendations that voluntary medical male circumcision 
(VMMC) be scaled up in settings where it would have the highest impact (4), 14 countries in sub-
Saharan Africa have rolled out VMMC, with an estimated 11.7 million men circumcised through 2016 
(5). Tanzania incorporated VMMC into its national HIV prevention strategy in 2009, with a goal of 
circumcising 2.2 million males aged 10-34 years by 2017 (6); as of September 2016, over 1.6 million 
VMMCs had been performed in the country (5). Although the priority population outlined in the 
national strategy is men aged 10-34 years, modelling data suggest that circumcising men aged 20-34 
years would yield a more immediate impact on HIV reduction (7-9).  
Studies have examined the cost and cost-effectiveness of VMMC in sub-Saharan Africa. 
Estimates of the average cost per surgical VMMC range from $29 in sites integrated into regular 
health facility activities in Kenya (10) to $158 in public hospitals in South Africa (11). Research has 
compared unit costs of VMMC across delivery modes (i.e. facility-based, mobile delivery, or 
outreach) indicates that lower unit costs are observed in fixed delivery sites compared to outreach 
or mobiles sites and that delivering VMMC in health centres is less costly than hospital-based 
delivery  (10-13). Staff and consumable supplies are the two largest cost drivers across delivery 
modalities, with capital costs also being substantial in mobile delivery sites (13, 14). Research on 
target regions suggests that rapid scale-up of VMMC would require substantial additional 
investment, particularly in the early stages, but could lead to high long-term savings if human 
resources constraints are properly addressed (13, 15, 16).    
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Studies modelling the cost-effectiveness of VMMC in terms of cost per HIV infection averted 
(9, 10, 13, 16-26) have shown wide differences in the projected cost per HIV infection averted: from 
$78 in Kenya (10) to $22,000 in Rwanda (26). Key factors underlying this variation include VMMC 
unit cost, projected protective effect of VMMC, HIV prevalence and incidence, time horizons 
considered, and VMMC coverage. A limited number of studies have looked at the cost per disability-
adjusted life years (DALYs) averted. These studies have suggested that VMMC is cost-effective (with 
cost per DALY averted ranging from $7 to $120) and, once incremental cost-effectiveness ratios 
(ICER) were calculated including antiretroviral treatment (ART) costs averted, VMMC appears to be 
cost-saving when compared to a no VMMC scenario (15, 20, 24, 27). 
Models have also suggested that programmes can be more cost-effective by targeting men 
in most at-risk age groups. In Zimbabwe, the modelled cost per HIV infection averted dropped from 
$1,035 when assuming the current age distribution (13-29 years of age) to $811 when only men 
aged 20-24 years were circumcised (17). Recent studies in Swaziland, Malawi, Uganda, South Africa 
and Tanzania suggest that the most cost-effective age group to target are men ages 15-34 (9, 22-25).  
 However, Tthese age-targeted models, however, have recognised limitations: they are not 
based on empirical data that account for variations in cost stemming from different demand 
creation and service delivery approaches, which may be necessary to increase uptake of VMMC 
services for those at highest risk. Previous studies have documented the barriers to client demand 
for VMMC (28-32). Lower levels of health-seeking behaviour in men, fear of pain and injections, 
perceptions of inconvenience with an outcome of partial protection against HIV, and minimal 
awareness of the health benefits of circumcision have been suggested as possible reasons for lower 
VMMC uptake. Locally-tailored demand creation approaches have been proposed as a way to 
overcome these challenges (33).  
As far as we are aware, no articles have been published either (i) presenting primary cost 
data on the resources needed to design and implement locally-tailored demand creation approaches 
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or (ii) analysing the outcomes resulting from these additional costs in terms of HIV infections and 
DALYs averted, which would allow policymakers to weigh the effect of additional investments 
against other HIV prevention strategies, and, more broadly, investments in other disease areas.  
This paper seeks to bridge that gap in the literature by analysing the cost and cost-
effectiveness of a targeted demand creation intervention in the context of a randomised-controlled 
trial (RCT) in Tanzania evaluating VMMC uptake among men aged 20-34 years in two settings with 
different HIV-prevalence rates (34).  
We also examine whether the incremental costs associated with a tailored demand creation 
strategy led to economies of scale.
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MMETHODS 
Setting and Trial 
An RCT was conducted in Njombe and Tabora regions of Tanzania in November-December 
2014 and February-March 2015, respectively. By the start of the intervention, VMMC coverage 
across age groups was higher in Njombe (80%) than in Tabora (55%) (35).but the absolute number of 
men ages 20-34 years was higher in Tabora than in Njombe (36) (see Supplemental Digital Content 1 
for details). HIV prevalence was higher in Njombe (14.8%) than in Tabora (6.4%) (37, 38). It is 
important to note that the intervention was carried out at different points of the agricultural cycle in 
the two regions: during the dry season in Tabora and rainy season in Njombe. 
It was also higher in Njombe for age groups 20-24, 25-29 and 30-34 years (97% v. 59%, 68% 
v. 51%, 53% v. 51%, respectively) (35).  
HIV prevalence was higher in Njombe (14.8%) than in Tabora (6.4%) (37, 38).  
The trial evaluated locally-tailored demand creation and delivery of VMMC services. In 
addition to all the standard demand creation components present in the control arms (which 
included elements of mass media engagement, community mobilisation and targeted service 
delivery), the following were added to the intervention arms: i) demand creation communication 
stressing non-HIV benefits of VMMC and the voluntary nature of HIV testing services (HTS) prior to-
VMMC; ii) additional peer promoters and the involvement of two circumcised men from the 
community as auxiliary peer promoters; iii) separate waiting and group education areas for men 
aged >20 years during service delivery; iv) engagement of female partners in community-based 
demand creation and education about post-circumcision healing and abstinence (see Supplemental 
Digital Content 21 for details on demand creation activities in both arms).  
Details of the trial design and outcomes have been published (34). The trial aimed to assess 
VMMC uptake among men aged 20-34 years following the locally-tailored demand creation strategy 
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described compared with the standard of care normally delivered. Ten clusters were randomly 
selected per region and evenly allocated to theacross control and intervention arms. Within each 
cluster, VMMC started in a ‘parent’ VMMC site. If the number of VMMCs fell below a predetermined 
threshold, a ‘spin-off’ VMMC site opened elsewhere within the cluster. VMMC sites were considered 
‘outreach’ sites because they offered VMMC services for a temporary period of time and were 
located in hard-to-reach areas. 
In both arms, pParent sites and spin-off sites received demand creation activities (for two 
weeks and one week, respectively) before surgical services were offered. VMMC services were 
carried out for 26-34 days in each parent site. Clinical staff remained in the cluster for the duration 
of the trial and did not perform any other clinical services other than the VMMCs. Spin-off sites 
received demand creation activities one week before circumcisions started. Sites stayed open for 
follow-up visits until a week after circumcisions ended. Surgeries were conducted using a mixture of 
reusable and disposable kits. 
Trial results showed that the total number of VMMC clients of all ages was higher in the 
intervention arms than in the control arms: 6,251 vs. 3,968, respectively (RR 1.4). Although the total 
number and proportion of clients aged 20-34 years were greater in the intervention arms, there was 
a non-significant difference in the proportion of men aged 20-34 years between intervention and 
control arms (11.3% v 14.7%, respectively) in Njombe, whereas a two-fold statistically-significant 
difference was observed in Tabora (27.5% v. 11.5%) (34). 
 
Costing Methods 
Costs of all activities related to demand creation activities, surgery (which includes HTS and 
waste management), demand creation and monitoring and supervision, HTS, and waste 
management for the control and intervention arms of the trial were included. Costs of, as well as 
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start-up activities for the intervention arms, namely (including orientation meetings for peer 
promoters and auxiliary peer promoters and the, development of demand creation materials (which 
includes, and formative research to determine user preferences), were included in the analysis. 
Start-up activities for the standard of care delivery and surgery training were excluded; these 
activities took place long before the start of the intervention and cost data were not available. 
The study adopted a provider’s perspective (i.e. costs of intervention delivery). A top-down 
costing approach (i.e. dividing overall programme costs by outputs) was used to account for 
inefficiencies, down time and wastage. Limitations of this approach (a lack of information on 
individual service provision and an over reliance on implementing organisation records) are 
acknowledged.   
Staff, supplies and capital costs (i.e. goods with a market value of ≥ $100 and useful life of 
over one year) for surgery and demand creation activities were calculated usingwith cluster-specific 
data for the demand creatio.n Cost data on resources used for clinical and demand creation 
activities were collected during the trial from every cluster. A top-down costing approach (i.e. 
dividing overall programme costs by outputs) was used to account for inefficiencies, down time and 
wastage. Limitations of this approach (a lack of information on individual service provision and an 
over reliance on implementing organisation records) are acknowledged. Staff, supplies and capital 
costs (i.e. goods with a market value of ≥ $100) were calculated with cluster-specific data for the 
demand creation, surgery, HTS, and waste management components of the intervention. Total 
monitoring and supervision costs and start-up costs (in the intervention arms) and monitoring and 
supervision costs were calculated and allocated across clusters in both arms. Costs of developing 
demand creation materials were annuatised over five years. Staff and supplies costs were allocated 
entirely to VMMC activities as no other health-related activities ran concurrently. Financial records 
of the implementing organisation and the Central Medical Stores catalogue were used to calculate 
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prices of supplies and capital goods (39). Useful life of reusable and capital goods were estimated by 
interviews with the implementing organisation. 
Costs per cluster were estimated and unit costs (average costs per VMMC) were calculated 
by dividing total cluster costs by the total number of circumcisions performed per cluster.  
The number of days worked by clinical and demand creation staff was ascertained by 
attendance record review. Supervision and start-up staff time was determined through interviews 
with the implementing organisation. The start-up period covered the weeks prior to the start of the 
intervention when peer promoters and auxiliary peer promoters were trained in-region. Salary costs 
were obtained from health care providers who conducted the VMMCs and averaged by clinical 
category. Demand creation staff were paid per diems at the standard rate of the implementing 
organisation. Supervision and start-up salary information was gathered from interviews and record 
review with the implementing organisation. 
Costs per cluster were estimated and unit costs (average costs per VMMC) were calculated 
by dividing total cluster costs by the total number of circumcisions performed per cluster. Cost 
drivers were explored by calculating average cluster cost components in each trial arm per region 
(i.e. total cost components across all cluster per arm/region divided by the total number of clusters 
in each arm/region).  
Cluster-level records were used to obtain data on types and volumes of supplies and capital 
goods. Financial records of the implementing organisation and the Central Medical Stores catalogue 
were used to calculate prices (39). Useful life of reusable and capital goods were estimated by 
interviews with the implementing organisation.Tests of statistical significance to examine cost 
differences between arms were not carried out due to the low number of clusters per region. 
Cost data were collected in Tanzanian shillings (Tsh) and converted to 2015 US dollars using 
an average rate of 2,130 Tsh per $1 (40). 
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Ethical approval was obtained from the London School of Hygiene & Tropical Medicine 
Research Ethics Committee, the Medical Research Coordinating Committee of the National Institute 
for Medical Research of Tanzania, and the U.S. Centers for Disease Control and Prevention 
Institutional Review Board. The study was also registered at ClinicalTrials.gov (NCT02376348). 
 
Effectiveness Analysis  
Data on the number, client age and location of VMMCs performed were obtained from the 
trial dataset (34). (35).Trial results showed that the total number of VMMC clients of all ages was 
higher in the intervention arms than in the control arms: 6,251 vs. 3,968, respectively (RR 1.4). 
Although the total number and proportion of clients aged 20-34 years were greater in the 
intervention arms, there was a non-significant difference in the proportion of men aged 20-34 years 
between intervention and control arms (11.3% v 14.7%, respectively) in Njombe, whereas a two-fold 
statistically-significant difference was observed in Tabora (27.5% v. 11.5%) (34). See Supplemental 
Digital Content 3 for a breakdown of the number of VMMC clients per age group, region and trial 
arm. 
 
The Decision Makers’ Program Planning Tool (DMPPT) version 2.1 was used to estimate the 
primary number of HIV infections averted over a 15 year time horizon from the total number  
VMMCs performed during the trial, as well as the costs saved from antiretroviral treatment 
(ART)ART averted (26, 41). Details on the calibrations and methods used in the Tool have been 
published (26, 41). The DMPPT used country and region-specific demographic data, epidemiological 
dynamics and ART costs (1-3, 9) and estimated the differential impact of VMMC by client age group. 
Therefore, effectiveness estimates take into account the age distributions of clients circumcised in 
the trial. 
Cost and Cost-Effectiveness of a Demand Creation Intervention to Increase Uptake of VMMC 
Spending More to Spend Less 
9 
 
Disability-adjusted life years (DALYs)DALYs averted following HIV infections averted as a 
result of VMMC were calculated using a standard approach (42). Life expectancy was set at 69 years 
(43) for both HIV-negative people and HIV-positive people on ART.  ART coverage in Tanzania was 
assumed to be 70% (44) and disability weights applied allowed for ART access variation. Annual cost 
of ART (including antiretroviral medications, related laboratory costs, staff costs and overheads) was 
assumed to be $515 per patient. Averting an HIV infection would avert 21.2 DALYs for an individual 
without ART access, while just 3.26 DALYs would be averted among an individual using ART. A 
standard 3% discount rate was applied to costs and numbers of infections DALYs averted. 
Supplemental Digital Content 2 4 summarises input variables used to calculate infections and DALYs 
averted (1-3, 9, 26, 41, 43-48).  
 
Cost-Effectiveness and Sensitivity Analysis 
The primary outcome of analysis is the incremental cost-effectiveness ratio (ICER) estimated 
by comparing cost per DALY averted using a tailored demand creation approach against cost per 
DALY averted using the standard of care approach. Intermediate measures are total cost per cluster 
and unit cost per VMMC, per HIV infection averted and per DALY averted.  
𝐶𝑂𝑆𝑇𝑇𝑎𝑖𝑙𝑜𝑟𝑒𝑑 𝑑𝑒𝑚𝑎𝑛𝑑 𝑐𝑟𝑒𝑎𝑡𝑖𝑜𝑛 𝑎𝑝𝑝𝑟𝑜𝑎𝑐ℎ − 𝐶𝑂𝑆𝑇𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑜𝑓 𝐶𝑎𝑟𝑒 
𝐷𝐴𝐿𝑌𝑠𝑇𝑎𝑖𝑙𝑜𝑟𝑒𝑑 𝑑𝑒𝑚𝑎𝑛𝑑 𝑐𝑟𝑒𝑎𝑡𝑖𝑜𝑛 𝑎𝑝𝑝𝑟𝑜𝑎𝑐ℎ  −  𝐷𝐴𝐿𝑌𝑠𝑆𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑜𝑓 𝐶𝑎𝑟𝑒
 
A univariate deterministic sensitivity analysis was carried out to measure the effect of 
uncertainty on a number of different parameters (including ART coverage and cost, time horizon and 
supplies costs) on the ICERs. 
Ethical approval was obtained from the London School of Hygiene & Tropical Medicine 
Research Ethics Committee, the Medical Research Coordinating Committee of the National Institute 
for Medical Research of Tanzania, and the U.S. Centers for Disease Control and Prevention 
Institutional Review Board. The study was also registered at ClinicalTrials.gov (NCT02376348). 
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RESULTS 
The average total cost per cluster was $41,871 (min: $34,726 – max: $58,290). The average 
total costs per cluster in the control arms were nearly 20% lower than in the intervention arms: 
$39,968 ($34,726 – $45,538) vs. $50,358 ($40,087 – $58,290), respectively (Supplemental Digital 
Content 3). Average total costs per cluster were higher in the intervention arms than in the control 
arms both in Njombe ($39,105 and $46,696, respectively) and in Tabora ($40,443 and $54,408, 
respectively). The breakdown by cost category (as percentage of total cost) was similar between 
control and intervention arms, with recurrent staff costs accounting for the largest portion e 
majority of total costs (74.3% and 70.1%, respectivelybetween 68% and 80%). The majority of these 
staff costs were related to surgery. As percentages of total cost, surgery-related staff costs were 
higher in the control arms than in the intervention arms (59.9% vs. 54.5%, respectively), but  
dDemand creation-related staff costs were over two times higher in the intervention arms than in 
the control arms ($6,577 v. $2,438, respectively) (6.5% vs. 3.1%) (Table 1).  
Given the VMMC delivery model implemented, the majority of costs across both arms of the 
trial can be considered cluster-level fixed costs (i.e. costs that remain constant at the cluster level 
independent of outcome). Only consumable surgery supplies can be considered variable costs (i.e. 
costs that vary with output), and they accounted for 4% to 6%of total costs in Njombe and 12%-13% 
in Tabora. Tests of statistical significance to examine cost differences between arms were not carried 
out due to the low number of clusters per region.  
 
<<Insert Table 1: Breakdown of average cluster costs by region and arm (USD and %)Total cost 
breakdown by region and arm (USD and %)>> 
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The average unit cost (per VMMC) across all clusters in both trial arms was $89. Average 
costs per VMMC per cluster varied greatly: between $40.86 and $336.66. Average costs per VMMC 
per cluster arm were lower in the intervention clusters than in the control clusters: $81.34 65 (min: 
$47.13 – max: $183.88) vs. $101.3148.10 (min: $40.86 – max: $340.45), respectively. They were also, 
on average across both arms, more than two times lower in Tabora than in Njombe: $65.0174.66 
(min: $40.86 – max: $146.83) vs. $152.0276.61 (min: $102.27 – max: $340.45), respectively. Cluster-
specific unit costs and total VMMCs can be found in Supplemental Digital Content 5. (Supplemental 
Digital Content 3). An inverse relation between number of VMMCs performed per cluster and unit 
costs per cluster can be observed: the more VMMCs performed, the lower the unit cost. The 
Pearson’s correlation coefficient between the two variables was -0.81 (Figure 1).  
 
<<Insert Figure 1: Plot graph of average cost per VMMC per cluster>> 
 
The impact of VMMC on HIV infections averted over 15 years would be greater in the 
intervention arm than in the control arm across the two regions: 287 infections would be averted 
compared to 169, respectively (see Table 2). Although the total number of VMMCs was higher in 
Tabora than Njombe, the impact on HIV infections averted was projected to be higher in Njombe 
than in Tabora, with 266 infections averted compared to 190, respectively, due to higher projected 
HIV incidence in Njombe. The costs per HIV infection averted were lower in the intervention arm 
than in the control arm both in Njombe ($1,424 vs. $1,91744) and in Tabora ($2,212188 vs. 
$3,01835).  
Similar trends emerged in DALYs averted (see Table 2). In total, more DALYs were averted in 
the intervention arms (2,468) than in the control arms (1,444). Again, despite fewer total VMMCs in 
Njombe than in Tabora, 2,280 DALYs were averted in Njombe and 1,632 in Tabora. The costs per 
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DALY averted were lower in the intervention arm than in the control arm in Njombe ($166 v. 
$226224) and in Tabora ($255 257 v. $353354).  
 
<<Insert Table 2: Effectiveness: HIV infections averted, DALYs averted, and costs>> 
 
The ICERs of DALYs averted (without including cost savings from ART costs avoided from 
clients who did not acquire HIV) were $67 71 in Njombe and $139 143 in Tabora. However, when 
ART cost savings were considered, cost savings were achieved resulting in negative ICERs in both 
regions (See Figure 2). 
 
<<Insert Figure 2: Incremental cost-effectiveness plane>> 
 
Univariate sensitivity analysis suggests that the ICERs were relatively robust to variations in 
VMMC cost inputs. The greatest impact on the ICERs was driven by the cost of ART. ICERs remained 
negative in all variations tested, indicating that the demand creation intervention would remain 
cost-saving under most scenarios. Modifying the yearly cost of ART between $175 and $1,545 (one-
third to three times the base cost) led to variations in the base-case ICERs from -221-233% to 7178% 
in Njombe and from -272-287% to 8796% in Tabora. The variables examined held the same hierarchy 
in both regions in terms of relative sensitivity (Figure 3).  
 
<<Insert Figure 3: Tornado diagrams of the percentage changes in the base-case incremental cost-
effectiveness ratios (including averted costs of ART) from a deterministic one-way analysis of key 
input variables per region>> 
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DISCUSSION 
To our knowledge, this is the first economic evaluation examining a locally-tailored demand 
creation strategy to improve uptake of VMMC among target populations.  
In summary, our study found economies of scale in provision of VMMC service associated 
with the intervention of tailored demand creation. AlthoughDespite initially higher costs associated 
with the demand creation activities were incurred in the intervention arms, the unit costs per VMMC 
were lower in the intervention arms due to increased uptake. Despite higher unit costs and lack of 
impact of the intervention on the proportion of clients in the 20-34 year age group in Njombe, costs 
per infection averted and per DALY averted were lower due to higher project HIV incidence, due to a 
higher projected HIV incidence. When taking into account the costs of ART provision avoided due to 
HIV cases averted, providing VMMCs was cost-saving in both arms of the trial and across the two 
regions. However, the intervention arms were more cost-saving than the control arms.  
 
Staff costs made up the largest proportion of costs in both arms of the trial, followed by 
supplies. Although this is consistent with other studies, staff costs as a percentage of total cost were 
higher in our study than in others (13, 49). This is likely due to the service delivery strategy used. in 
the intervention (discussed below). As expected, the cost of the demand creation activities as a 
proportion of total cost was higher in the intervention arms than in the control arms;. tThe main 
incremental costs associated with the tailored demand creation were two extra peer promoters per 
intervention cluster and two auxiliary promoters. Despite the added demand creation costs, these 
activities increased the total number of clients in both regions and the proportion of clients aged 20-
34 years in Tabora. Minor differences in cluster-level fixed costs (i.e. costs that remain constant 
independent of output) such as capital goods and reusable items were observed, likely due to 
limitations in the top-down costing approach.  
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Most other studies utilised ingredients-based costing, which only capture direct time spent 
providing VMMC services. This study used a top-down costing approach which accounts for all staff 
costs, whether or not the staff were fully utilized; this may explain our relatively-higher staff costs. 
The service delivery approach employed in our studythe trial (in both arms) required all VMMC staff 
to remain in the same cluster for a minimum of four weeks regardless of client volume and to not 
perform other clinical activities. In routine service delivery (i.e. non-research), staff move frequently, 
as dictated by client volume. Therefore, staff costs in our study can be considered to be fixed costs. 
One other published study had a similar delivery method to ours, although in their case the mobile 
clinics remained in the field for fewer days (12 on average v. approximately 30 in our study) (12).   
Although these higher costs related to fixed clinical staff could be interpreted as an 
inefficiency, this approach may be an essential component of an effective strategy in delivering 
services to harder-to-reach populations. Whether staff-heavy modalities of delivery are essential to 
an increased uptake of VMMC among harder-to-reach clients needs to be assessed and piloted in 
routine service delivery settings. 
Our findings suggest that economies of scale were achieved.  Despite greater total costs in 
the intervention arms, costs per VMMC were higher in the control arms. Figure 1 shows that the 
higher the number of VMMCs per cluster, the lower the unit costs, likely due to the high proportion 
of cluster-level fixed costs (between 87% and 96%). Again, this is likely due to fixed surgery staff 
costs.   across both arms and regions. Although it is beyond the scope of this paper to explore 
economies of scale in detail (and further work in this area, such as cost function analyses, would be a 
worthwhile endeavour), our study suggests that once the initial costs of setting up a cluster are 
incurred a lower cost per VMMC can be attained if demand creation activities succeed in attracting 
more uncircumcised men. 
The average cost per HIV infection averted ranged from $1,424 in the intervention arm in 
Njombe to $3,018 in the control arm in Tabora. These costs were within the ranges found in other 
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studies, although the range is extremely wide. Although average unit costs per VMMC were higher in 
Njombe for both the control and intervention arms, the average costs per HIV infection averted and 
per DALY averted were lower in Njombe. Fewer people were circumcised during the trial in Njombe, 
but the impact per circumcision on HIV acquisition was projected to be greater in that region due to 
higher projected HIV incidence. In both regions, the average cost per HIV infection averted and cost 
per DALY averted were lower in the intervention arms than in the control arms. The locally-tailored 
demand creation strategy in the intervention arm required additional start-up costs (orientation 
meetings and a demand creation design stage, including formative research) as well as additional 
demand creation staff (peer promoters and auxiliary peer promoters) and additional demand 
creation supplies (i.e. more flyers and banners, etc.). However, the average cost per HIV infection 
averted and cost per DALY averted were lower in the intervention arms than in the control arms in 
both regions. In both regions, the average cost per HIV infection averted and cost per DALY averted 
were lower in the intervention arms than in the control arms.This suggests that additional spending 
on demand creation, which in turn may lead to higher demand, is justified as it makes the 
intervention more cost-effective than the standard of care. 
Although average unit costs per VMMC were higher in Njombe for both the control and 
intervention arms, the average costs per HIV infection averted and per DALY averted were lower in 
Njombe. Fewer people were circumcised during the trial in Njombe, but the impact per circumcision 
on HIV acquisition was projected to be greater in that region due to higher projected HIV incidence. 
This would suggest that extra spending on tailored demand creation is justified, as the 
intervention is more cost-effective than the standard of care. In other words, creating higher 
demand leads to lower unit costs.  This would suggest that extra spending on tailored demand 
creation is justified, as the intervention is more cost-effective than the standard of care. 
The average cost per infection averted ranged from $1,424 in the intervention arm in 
Njombe to $3,036 in the control arm in Tabora. These costs were within ranges found in other 
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studies, although the range is extremely wide. Costs per DALY averted as a result of VMMC have not 
been widely reported in the literature. Total costs of the intervention decreased when incorporating 
cost savings attributable to ART treatment averted. The ICERs for both regions were negative: the 
intervention dominated the control in terms of cost-effectiveness as the intervention was both less 
expensive and more effective. We therefore found that the intervention was not only cost-effective 
under the approaches examined, but was also  more cost-saving. Other studies have also found that 
VMMC is cost-saving when compared to a no VMMC scenario once accounting for ART costs averted 
(15, 20, 24, 27). However, our findings are novel because they show that the locally-tailored demand 
creation approach in the intervention is cost-saving, not only in relation to the no VMMC scenario, 
but also to the standard of care approach. 
It is important to note, however, that as coverage of VMMC increases in the future, greater 
efforts will need to be made to reach an increasingly small number of uncircumcised men. Demand 
creation strategies may need to be strengthened or modified, incurring additional cost. These 
changes could potentially make the intervention less cost-effective. 
While the intervention increased overall VMMC uptake, the proportion of men in the target 
age range did not increase significantly in Njombe. Despite this, we found that, even if cost savings 
were observed in both regions, impact and cost-effectiveness in Tabora were lower than in Njombe. 
This suggests that the overall projected HIV incidence may be more important than client age in 
determining cost-effectiveness of VMMC.  
 
 
Limitations 
We may have underestimated the cost-effectiveness (DALYs averted) of the intervention for 
several reasons: (i) while VMMC reduces the risk of acquiring other infections (50), our study only 
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considers the costs related to averting HIV infections; (ii) the DMPPT model is not dynamic and thus 
the number of secondary HIV infections averted are underestimated; and (iii) the trial design 
required that staff stay in one cluster regardless of the number of daily clients while in a non-study 
setting staff would relocate according to client volume, meaning our staff costs are likely higher 
when compared to other services utilising outreach models. Conversely, we may have overestimated 
the cost-effectiveness of the intervention by not including start-up and training costs for the control 
arms. 
Patient costs were not included in this study. Given the period of recommended physical 
inactivity post-VMMC, the costs of wages lost to the individual may be substantial (51). A separate 
analysis of patient costs may identify their effect on VMMC uptake.   
The intervention arms had several components. However, activity-specific costs and effects 
were not disaggregated. Future research could look at which specific components yield the greatest 
uptake of VMMC, and the consequent cost implications.  
Some of the costs in our study, such as monitoring and supervision costs, were collected for 
each region and could not be disaggregated at the cluster level. Therefore we allocated these costs 
equally across clusters in the same region, potentially underestimating the costs in clusters that 
required greater oversight. 
Trial implementation took place during the dry season in Tabora and the rainy season in 
Njombe, when more agricultural activity takes place. This may have led to differences in 
implementation costs and demand for services among men of productive ages.  
Three separate, self-contained models and tools were used (costs, DMPPT, and DALYs) and 
therefore a combined probabilistic sensitivity could not be undertaken. Consequently our analysis 
does not capture full uncertainty.  
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In summary, our study found economies of scale in provision of VMMC service associated with the 
intervention of tailored demand creation. Despite initially higher costs associated with the demand 
creation activities, the unit costs per VMMC were lower in the intervention arms due to increased 
uptake. Despite higher unit costs and lack of impact of the intervention on the proportion of clients 
in the 20-34 year age group in Njombe, costs per infection averted and per DALY averted were 
lower, due to a higher projected HIV incidence. When taking into account the costs of ART provision 
avoided due to HIV cases averted, providing VMMCs was cost-saving in both arms of the trial and 
across the two regions. However, the intervention arms were more cost-saving than the control 
arms.  
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